Literature DB >> 22886101

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

O Ström1, F Borgström, John A Kanis, Juliet Compston, Cyrus Cooper, Eugene V McCloskey, Bengt Jönsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22886101     DOI: 10.1007/s11657-011-0060-1

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


× No keyword cloud information.
  160 in total

Review 1.  Fracture Liaison Services in an open system: how was it done? what were the barriers and how were they overcome?

Authors:  Manju Chandran
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

2.  One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.

Authors:  C Reyes; C Tebe; D Martinez-Laguna; M S Ali; A Soria-Castro; C Carbonell; D Prieto-Alhambra
Journal:  Osteoporos Int       Date:  2017-07-16       Impact factor: 4.507

3.  [Challenges of implementing a geriatric trauma network : A regional structure].

Authors:  Carsten Schoeneberg; Bjoern Hussmann; Thomas Wesemann; Ludger Pientka; Marie-Christin Vollmar; Christine Bienek; Markus Steinmann; Benjamin Buecking; Sven Lendemans
Journal:  Unfallchirurg       Date:  2018-04       Impact factor: 1.000

Review 4.  Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health.

Authors:  Ryan P Farmer; Benoit Herbert; Derly O Cuellar; Jiandong Hao; Philip F Stahel; Robin Yasui; David J Hak; Cyril Mauffrey
Journal:  Int Orthop       Date:  2014-03-21       Impact factor: 3.075

Review 5.  [Treatment of patients with fragility fractures].

Authors:  B Bücking; C Neuerburg; M Knobe; U Liener
Journal:  Unfallchirurg       Date:  2019-10       Impact factor: 1.000

Review 6.  [Management of osteoporosis after fragility fractures].

Authors:  M Gosch; U Stumpf; C Kammerlander; W Böcker; H J Heppner; S Wicklein
Journal:  Z Gerontol Geriatr       Date:  2018-01-05       Impact factor: 1.281

7.  Quality of life, resource use, and costs related to hip fracture in Estonia.

Authors:  M Jürisson; H Pisarev; J Kanis; F Borgström; A Svedbom; R Kallikorm; M Lember; A Uusküla
Journal:  Osteoporos Int       Date:  2016-02-23       Impact factor: 4.507

8.  The Association Between Bone Mineral Density and Airflow Limitation in a Cohort of Fit Elderly Women.

Authors:  Caterina Trevisan; A Vianello; N Veronese; S Carraro; S Pizzato; P Lucato; G Girotti; C Rinaldo; A Coin; E Manzato; G Sergi
Journal:  Lung       Date:  2016-10-03       Impact factor: 2.584

9.  The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis.

Authors:  P Hadji; D Felsenberg; M Amling; L C Hofbauer; J A Kandenwein; A Kurth
Journal:  Osteoporos Int       Date:  2013-10-03       Impact factor: 4.507

10.  Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women.

Authors:  Sun Min Oh; Byung-Ho Nam; Yumie Rhee; Seong-Hwan Moon; Deog Young Kim; Dae Ryong Kang; Hyeon Chang Kim
Journal:  J Bone Miner Metab       Date:  2013-02-19       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.